Authors:
DREIHER J
SHPILBERG O
RAAMAMI P
CHETRIT A
BENBASSAT I
Citation: J. Dreiher et al., THE MACOP-B AND VACOP-B COMBINATION CHEMOTHERAPY FOR YOUNG-PATIENTS WITH INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA, Leukemia research, 22(11), 1998, pp. 997-1002
Authors:
COLLINS RH
SHPILBERG O
DROBYSKI WR
PORTER DL
GIRALT S
CHAMPLIN R
GOODMAN SA
WOLFF SN
HU W
VERFAILLIE C
LIST A
DALTON W
OGNOSKIE N
CHETRIT A
ANTIN JH
NEMUNAITIS J
Citation: Rh. Collins et al., DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 15(2), 1997, pp. 433-444
Citation: O. Shpilberg et al., MOLECULAR EPIDEMIOLOGY OF HEMATOLOGICAL NEOPLASMS - PRESENT STATUS AND FUTURE-DIRECTIONS, Leukemia research, 21(4), 1997, pp. 265-284
Authors:
BURSTEIN R
SEIDMAN DS
ZEMER D
SHPILBERG O
ARNON R
EPSTEIN Y
PRAS M
Citation: R. Burstein et al., CHRONIC COLCHICINE TREATMENT DOES NOT IMPAIR GLUCOSE-TOLERANCE IN FAMILIAL MEDITERRANEAN FEVER PATIENTS, European Journal of Clinical Pharmacology, 52(1), 1997, pp. 27-30
Authors:
PERETZ H
MULAI A
USHER S
ZIVELIN A
SEGAL A
WEISMAN Z
MITTELMAN M
LUPO H
LANIR N
BRENNER B
SHPILBERG O
SELIGSOHN U
Citation: H. Peretz et al., THE 2 COMMON MUTATIONS CAUSING FACTOR-XI DEFICIENCY IN JEWS STEM FROMDISTINCT FOUNDERS - ONE OF ANCIENT MIDDLE-EASTERN ORIGIN AND ANOTHER OF MORE RECENT EUROPEAN ORIGIN, Blood, 90(7), 1997, pp. 2654-2659
Authors:
RAANANI P
SHPILBERG O
GILIS S
AVIGDOR A
HARDAN I
BERKOWICZ M
SOFER O
LOSSOS I
CHETRIT A
BENYEHUDA D
BENBASSAT I
Citation: P. Raanani et al., SALVAGE THERAPY OF REFRACTORY ACUTE-LEUKEMIA WITH HIGH-DOSE MITOXANTRONE AND CYTARABINE, Blood, 90(10), 1997, pp. 3842-3842
Citation: R. Or et al., LOW MOLECULAR-WEIGHT HEPARIN STIMULATES MEGAKARYOCYTOPOIESIS IN BONE-MARROW TRANSPLANTATION PATIENTS, American journal of hematology, 53(1), 1996, pp. 46-48
Authors:
SHAKED Y
SHPILBERG O
SHAKED N
RUBINSTEIN E
DOUER D
Citation: Y. Shaked et al., IN-VITRO EFFECTS OF A COMBINATION OF ZIDOVUDINE AND ACYCLOVIR ON GROWTH OF NORMAL HUMAN MYELOID PROGENITOR CELLS, American journal of hematology, 51(4), 1996, pp. 329-330
Authors:
OR R
NAGLER A
SHPILBERG O
ELAD S
NAPARSTEK E
KAPELUSHNIK J
CASS Y
GILLIS S
CHETRIT A
SLAVIN S
ELDOR A
Citation: R. Or et al., LOW-MOLECULAR-WEIGHT HEPARIN FOR THE PREVENTION OF VENOOCCLUSIVE DISEASE OF THE LIVER IN BONE-MARROW TRANSPLANTATION PATIENTS, Transplantation, 61(7), 1996, pp. 1067-1071
Authors:
BURSTEIN R
COWARD AW
ASKEW WE
CARMEL K
IRVING C
SHPILBERG O
MORAN D
PIKARSKY A
GINOT G
SAWYER M
GOLAN R
EPSTEIN Y
Citation: R. Burstein et al., ENERGY-EXPENDITURE VARIATIONS IN SOLDIERS PERFORMING MILITARY ACTIVITIES UNDER COLD AND HOT CLIMATE CONDITIONS, Military medicine, 161(12), 1996, pp. 750-754
Authors:
BURSZTYN M
SHPILBERG O
GINSBERG GM
COHEN A
STESSMAN J
Citation: M. Bursztyn et al., HYPERTENSION IN THE JERUSALEM 70 YEAR OLDS STUDY POPULATION - PREVALENCE, AWARENESS, TREATMENT AND CONTROL, Israel journal of medical sciences, 32(8), 1996, pp. 629-633
Citation: O. Shpilberg et I. Benbassat, PREGNANCY IN WOMEN WITH ESSENTIAL THROMBOCYTHEMIA - REPLY, British Journal of Haematology, 93(4), 1996, pp. 977-977
Authors:
SHPILBERG O
SHIMON I
SOFER O
DOLITSKI M
BENBASSAT I
Citation: O. Shpilberg et al., TRANSIENT NORMAL PLATELET COUNTS AND DECREASED REQUIREMENT FOR INTERFERON DURING PREGNANCY IN ESSENTIAL THROMBOCYTHEMIA, British Journal of Haematology, 92(2), 1996, pp. 491-493
Authors:
SHPILBERG O
BLUMENTHAL R
SOFER O
KATZ Y
CHETRIT A
RAMOT B
ELDOR A
BENBASSAT I
Citation: O. Shpilberg et al., A CONTROLLED TRIAL OF TRANEXAMIC ACID THERAPY FOR THE REDUCTION OF BLEEDING DURING TREATMENT OF ACUTE MYELOID-LEUKEMIA, Leukemia & lymphoma, 19(1-2), 1995, pp. 141-144
Authors:
SHPILBERG O
MARK Z
BINIAMINOV M
ROSNER E
ROSENTHAL E
GIPSH N
RUBANOV V
RACHMILEWITZ E
BROKSIMONI F
RECHAVI G
BENBASSAT I
Citation: O. Shpilberg et al., TRANSFORMATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA TO MULTIPLE-MYELOMA - CLONAL EVOLUTION OR 2ND MALIGNANCY, Leukemia, 9(11), 1995, pp. 1974-1978
Authors:
NAGLER ROA
SHPILBERG O
ELAD S
NAPARSTEK E
KAPELUSHNIK J
GILLIS S
CASS Y
CHETRIT A
SLAVIN S
ELDOR A
Citation: Roa. Nagler et al., LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) MAY PREVENT VENOOCCLUSIVE DISEASE(VOD) AND INDUCE ACCELERATED PLATELETS RECOVERY FOLLOWING BONE-MARROWTRANSPLANTATION (BMT), Thrombosis and haemostasis, 73(6), 1995, pp. 974-974
Citation: I. Shimon et O. Shpilberg, THE INSULIN-LIKE GROWTH-FACTOR SYSTEM IN REGULATION OF NORMAL AND MALIGNANT HEMATOPOIESIS, Leukemia research, 19(4), 1995, pp. 233-240
Authors:
SHPILBERG O
HADDAD N
SOFER O
RAANANI P
BERKOWICZ M
CHETRIT A
CARTER A
RAMOT B
TATARSKI I
BENBASSAT I
Citation: O. Shpilberg et al., POSTREMISSION THERAPY WITH 2 DIFFERENT DOSE REGIMENS OF CYTARABINE INADULTS WITH ACUTE MYELOGENOUS LEUKEMIA, Leukemia research, 19(12), 1995, pp. 893-897
Authors:
SEGAL E
BENABRAHAM R
SHPILBERG O
HARDAN I
BENBASSAT I
PEREL A
Citation: E. Segal et al., HEMATOONCOLOGY PATIENTS WITH ACUTE RESPIRATORY-FAILURE (ARF) IN THE ICU, British Journal of Anaesthesia, 74, 1995, pp. 110-110